Abstract
Low-dose antibiotics: current status and outlook for the future.
Highlights
Antimicrobial therapy is a key factor in our success against pathogens poised to ravage at risk or infected individuals
The host modulatory aspects of macrolides, tetracyclines, and betalactams are reviewed by Aminov (2013a) underscoring how, for example, macrolides such as azithromycin are routinely used for immunomodulation in patients with chronic pulmonary disease rather than for an antimicrobial effect
Azithromycin is used as a tool by Imperi et al to detail how non-conventional thinking about regulating virulence factors or modifying host inflammatory cascades are useful to combating major pathogens such as Pseudomonas aeruginosa (Imperi et al, 2014)
Summary
Antimicrobial therapy is a key factor in our success against pathogens poised to ravage at risk or infected individuals. The host modulatory aspects of macrolides, tetracyclines, and betalactams are reviewed by Aminov (2013a) underscoring how, for example, macrolides such as azithromycin are routinely used for immunomodulation in patients with chronic pulmonary disease rather than for an antimicrobial effect.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
